G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...

Vivani Medical (Nasdaq:VANI) today announced steps enabling it to focus solely on its GLP-1-delivering implant technologies.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...

By Brian Brown, president and partner at food marketing agency Ingredient  For those living on the West Coast of North ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.